Search

Your search for "globaldata chemotherapy induced acral erythema hand foot syndrome global clinical trials review h1" gave back 83405 results.
Acral erythema, also called as hand-foot syndrome or palmar-plantar erythrodysesthesia, is characterized by swelling, redness, paraesthesia (numbness...
LPI
March 2023
Price: USD 3,660.00
Acral erythema, also called as hand-foot syndrome or palmar-plantar erythrodysesthesia, is characterized by swelling, redness, paraesthesia (numbness...
MRRPB5
July 2023
Price: USD 4,900.00
Acral erythema, also called as hand-foot syndrome or palmar-plantar erythrodysesthesia, is characterized by swelling, redness, paraesthesia (numbness...
MRRPB5
March 2024
Price: USD 2,900.00
Acral erythema, also called as hand-foot syndrome or palmar-plantar erythrodysesthesia, is characterized by swelling, redness, paraesthesia (numbness...
MRRPB5
April 2023
Price: USD 2,900.00
Market Analysis and Insights: Global Chemotherapy Induced Acral Erythema Treatment Market The global Chemotherapy Induced Acral Erythema Treatment...
MRRPB5
September 2023
Price: USD 4,900.00
Acral Lentiginous Melanoma Drugs, a lymphokine, is produced by recombinant DNA technology using a genetically engineered E. coli strain containing an...
Catalog: 
MRRPB5
September 2023
Price: USD 2,900.00
CIPN is a common adverse effect of several cancer therapies including taxanes and platinum drugs. Symptoms include decreased sensation and tingling...
Catalog: 
MRRPB5
January 2023
Price: USD 4,000.00
Acral Lentiginous Melanoma Drugs, a lymphokine, is produced by recombinant DNA technology using a genetically engineered E. coli strain containing an...
Catalog: 
MRRPB5
September 2023
Price: USD 2,900.00
Acral Lentiginous Melanoma Drugs, a lymphokine, is produced by recombinant DNA technology using a genetically engineered E. coli strain containing an...
Catalog: 
MRRPB5
September 2023
Price: USD 2,900.00
Acral Lentiginous Melanoma Drugs, a lymphokine, is produced by recombinant DNA technology using a genetically engineered E. coli strain containing an...
Catalog: 
MRRPB5
January 2024
Price: USD 2,900.00
Acral Lentiginous Melanoma Drugs, a lymphokine, is produced by recombinant DNA technology using a genetically engineered E. coli strain containing an...
Catalog: 
MRRPB5
January 2024
Price: USD 2,900.00
Acral Lentiginous Melanoma Drugs, a lymphokine, is produced by recombinant DNA technology using a genetically engineered E. coli strain containing an...
Catalog: 
MRRPB5
January 2024
Price: USD 2,900.00
CIPN is a common adverse effect of several cancer therapies including taxanes and platinum drugs. Symptoms include decreased sensation and tingling...
LPI
January 2023
Price: USD 3,660.00
The global Chemotherapy Induced Peripheral Neuropathy Treatment market size was valued at US$ 1638.7 million in 2023. With growing demand in...
LPI
January 2024
Price: USD 3,660.00
CIPN is a common adverse effect of several cancer therapies including taxanes and platinum drugs. Symptoms include decreased sensation and tingling...
Catalog: 
MRRPB5
November 2023
Price: USD 3,350.00

Contact Us for Custom Market Research Solutions

 

Custom Market Research Reports

Filter By Industry

Filter By Country

Clients Who Trust Us

Market Research Reports Inc. Customers

Need tailor made market research solution? We can help you with that too.

About Us

At Market Research Reports, Inc. we aim to make it easier for decision makers to find relevant information and locate right market research reports which can save their time and assist in what they do best, i.e. take time-critical decisions.

We work with our associate Global market research firms who are known leaders in their respective domains to obtain right market research solution for our customer’s needs, be it custom research or syndicated research reports.

Contact Us

Market Research Reports, Inc
16192 Coastal Hwy
Lewes
, DE 19958, USA

USA: +1-302-703-9904

India: +91-8762746600

marketresearchreports

info@marketresearchreports.com

User login

Stay Connected